Senate LDA lobbying filing
ABBOTT LABORATORIES
Registrant: W STRATEGIES, LLC Year: 2024 Period: Fourth Quarter Type: Q4
Reported income
$50.0K
Reported expenses
not reported
Tracked program mentions1
Quoted activity text is clipped to a short extract; each filing’s full description is under Lobbying activities below.
H.R.4128: VALID Act of 2021. H.R.7213 - Equitable Community Access to Pharmacist Services Act. Issues related to…
Lobbying activities1
Health IssuesHCR
H.R.4128: VALID Act of 2021. H.R.7213 - Equitable Community Access to Pharmacist Services Act. Issues related to infant formula access.
Lobbyists1
- DARREN WILLCOX
Source: U.S. Senate Lobbying Disclosure Act database. Dollar figures (underlined) cite the filing record on lda.senate.gov — click to view the citation. Amounts shown as “not reported” are absent from the filing itself.